drugset / Trial / NCT04201275
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this study is to assess the tolerability, pharmacokinetics and antiviral activity of HEC74647 in HCV treatment naïve subjects with genotypes 1-6.
Timeline
- Start
- 2019-12-18
- Primary completion
- 2020-01-17
- Completion
- 2020-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HEC74647PA | Unknown | 50 mg | Oral |
| Subject | HEC74647PA | Unknown | 100 mg | Oral |
| Subject | HEC74647PA | Unknown | 200 mg | Oral |